Innovative Approach to Clinical Plan: Virtual Trial Design.

Health app designed to engage users through increased healthful living styles are at the base of this innovation in clinical plan and trial design.

The design of the Health app was a collaborative effort between Janssen Pharmaceuticals and Apple Watch. The randomized trial is designed to determine if wearable technology can detect atrial fibrillation (AFib).

The trial objective is to help researchers improve clinical outcomes for people with AFib. The app may be able to motivate users to follow an active, healthful lifestyle and boost patient compliance to prescribed medicine.

Researchers may be able to answer whether anti-coagulants can improve outcomes following an AFib diagnosis, and whether these medications prevent strokes and more.

With ~ 150,000 participants, this will be a landmark trial. Designing innovative ways to conduct clinical plan and trials, experiencing use of wearable technology as well methodology can be merged in the SCIO process.

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Phone

This field is for validation purposes and should be left unchanged.